-
Anadar raises the prices of main products three times in two months. Leading companies raise prices collectively. Titanium dioxide industry welcomes peak season
Time of Update: 2022-06-24
Affected by the global epidemic, in the first half of this year, the market demand for titanium dioxide "increased first and then decreased", the price declined, and competition in the domestic market was fierce .
-
The increase of this factor will actually lead to an increase in the mortality rate of rheumatoid patients?
Time of Update: 2022-06-20
*For medical professionals to read and refer to clinical information, 1s touches ▎Clinical question: Is there a correlation between adipokines levels and the prognosis of rheumatoid arthritis (RA) patients?
-
and lead in rice. Rapid extraction-inductively coupled plasma mass spectrometry
Time of Update: 2022-06-17
Center, Steel Research Nake Testing Technology Co. , Ltd. , COFCO Nutrition and Health Research Institute Co. , Ltd. , Shaanxi Provincial Grain and Oil Product Quality Supervision and Inspection Center , Hunan Grain
-
Your baby's birth weight is linked to lifetime diabetes risk -- the lower your body weight, the sooner you may develop type 2 diabetes
Time of Update: 2022-06-13
Lower birth weight may be associated with lower age at onset of type 2 diabetes and BMI at diagnosis, according to a study published in the journal Diabetes Medicine .
-
Baby eat probiotics to prevent allergic diseases?
Time of Update: 2022-06-12
The study found that administering a probiotic supplement [Lactobacillus rhamnosus GG (LGG)] to high-risk infants during the first 6 months of life was not effective in reducing the incidence of eczema, asthma or rhinitis in later childhood .
-
What will lead the next revolution in cancer care in the next decade?
Time of Update: 2022-06-09
/>qq. com/s/-6wc6gQRB8ATfrrLPvf6VQ>[3] The road is coming, witnessing the industrialization of cell and gene therapy. Retrieved October 28, 2021, from https://mp. weixin. qq
-
New Era, Shared Future - Glutide Summit Leading the Trend, GLP-1RA Spectrum New Chapter
Time of Update: 2022-06-09
Glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs have accumulated a large amount of evidence-based medical evidence in recent years, and their status in the guidelines has gradually improved, providing a favorable means for patients to obtain satisfactory treatment.
-
Shorts play the leading role in the PE market in late September
Time of Update: 2022-06-08
It is expected that the market supply will increase significantly in the later period, and the trend of international crude oil is weak.
-
. Plastics will lead the development of the construction industry
Time of Update: 2022-06-06
Construction industry demand for green building surge, is expected to create a lot of growth opportunities for plastics construction market in the next few years.
-
Leading more than 40 Biotechs, Qilu stood out with 11 clinical trials, revealing Qilu's pipeline and strategy
Time of Update: 2022-06-05
> At the AACR meeting, in addition to several dual-antibody therapies, Qilu also announced several preclinical innovative products . Including two Fast-follow small-molecule innovative drugs, 4th
-
【Chinese Achievements】Professor Shen Lin from Beijing Cancer Hospital leads the International
Time of Update: 2022-06-04
NEJM: Results from the AGILE trial confirm significant improvement in ivonib plus azacitidine compared with placebo plus azacitidine in patients with newly diagnosed IDH1-mutant acute myeloid leukemia who are ineligible for induction chemotherapy Event-free survival, remission and overall survival .
-
is recommended by the whole population, leading a new journey in the treatment of upper gastrointestinal tumors
Time of Update: 2022-06-04
Last year, based on the CheckMate-649 study¹, the National Medical Products Administration (NMPA) approved nivolumab in combination with chemotherapy for first-line treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma, the first in China.
-
Job in the Training of Leading Talents in the Operation and Management of Small and Medium-sized Enterprises for 2020-2021
Time of Update: 2022-05-31
>training for leading talents in the management of small and medium-sized enterprises (hereinafter referred to as the leading talent training). The relevant matters are hereby notified as follows
-
Bayer poachs another GSK executive to lead its strategic oncology business unit
Time of Update: 2022-05-30
At Bayer, Roth and Frenkl will focus on developing the prostate cancer drug Nubeqa .
-
Build a display platform to present the four new achievements of the industry, lead the development
Time of Update: 2022-05-29
Equipment, and New Products Exhibition" (abbreviated as: 2020 China International Plastics Exhibition) press conference was held at Nanjing International Expo Held in the center . The organizer
-
Fetal exposure to drugs may affect baby's brain development
Time of Update: 2022-05-26
In utero exposure to maternal antiepileptic or antidepressant drugs may affect the development of brain networks in newborns, new research suggests .
-
Finding out baby's sex during pregnancy leads to better chances of survival: Boys are more demanding than girls before birth
Time of Update: 2022-05-25
are difficult to predict and treat . >Designing individual treatment plans and encouraging pregnant women to make life> . >
-
New research on repairing blood-brain barrier leads to innovative approach to treating multiple brain diseases
Time of Update: 2022-05-24
of thinking, however, is how to improve specificity . Because Wnt proteins and their Fz receptors are widely expressed in various cells and tissues, activation of Wnt signaling in other tissues
-
Nat Genet: Delaying DNA replication fork speeds leads to cell fate changes and enhances cell reprogramming efficiency
Time of Update: 2022-05-23
The relevant research results were published online in the journal Nature Genetics on March 7, 2022, with the title of "DNA replication fork speed underlies cell fate changes and promotes reprogramming" .
-
These pharmaceutical companies announced the first financial report after listing, and the word "profit" took the lead!
Time of Update: 2022-05-23
The report shows that the company will achieve operating income of 530 million yuan in 2021, a year-on-year increase of 8.
